IWM
NMTR

IHT Wealth Management’s 9 Meters Biopharma NMTR Stock Holding History

IHT Wealth Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-600
Closed -$3K – 953
2022
Q3 		$3K Buy
600
+100
+20% +$496 ﹤0.01% 868
2022
Q2 		$3K Hold
500
– – ﹤0.01% 738
2022
Q1 		$6K Hold
500
– – ﹤0.01% 764
2021
Q4 		$10K Hold
500
– – ﹤0.01% 802
2021
Q3 		$13K Hold
500
– – ﹤0.01% 799
2021
Q2 		$11K Buy
+500
New +$12.3K ﹤0.01% 938

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

IHT Wealth Management's NMTR Position: Q4 2022 in Review

IHT Wealth Management sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 600 shares — an estimated $3K sold.

IHT Wealth Management first reported a position in NMTR in Q2 2021 and held it in 6 quarters. The position peaked at $13K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • IHT Wealth Management reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • IHT Wealth Management sold 600 9 Meters Biopharma shares in Q4 2022, an estimated $3K.
  • IHT Wealth Management first reported a position in 9 Meters Biopharma in Q2 2021 and held it in 6 quarters.
  • IHT Wealth Management's 9 Meters Biopharma position peaked at $13K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on IHT Wealth Management's 13F filing for Q4 2022, filed 15 Feb 2023.